Distinct expression and prognostic value of members of the epidermal growth factor receptor family in ovarian cancer

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• TorreLATrabertBDesantisCEOvarian cancer statistics, 2018CA Cancer J Clin201868428429629809280
   PubMed Web of Science ®Google Scholar
• HolschneiderCHBerekJSOvarian cancer: epidemiology, biology, and prognostic factorsSemin Surg Oncol200019131010883018
   PubMedGoogle Scholar
• RoskoskiRThe ErbB/HER family of protein-tyrosine kinases and cancerPharmacol Res201479347424269963
   PubMed Web of Science ®Google Scholar
• Appert-CollinAHubertPCrémelGBennasrouneARole of ErbB Receptors in cancer cell migration and invasionFront Pharmacol2015628326635612
   PubMed Web of Science ®Google Scholar
• HymanDMPiha-PaulSAWonHHER kinase inhibition in patients with HER2- and HER3-mutant cancersNature2018554769118919429420467
   PubMed Web of Science ®Google Scholar
• HynesNEMacDonaldGErbB receptors and signaling pathways in cancerCurr Opin Cell Biol200921217718419208461
   PubMed Web of Science ®Google Scholar
• ShengQLiuJThe therapeutic potential of targeting the EGFR family in epithelial ovarian cancerBr J Cancer201110481241124521364581
   PubMed Web of Science ®Google Scholar
• WilkenJABadriTCrossSEGFR/HER-targeted therapeutics in ovarian cancerFuture Med Chem20124444746922416774
   PubMed Web of Science ®Google Scholar
• GuiTShenKThe epidermal growth factor receptor as a therapeutic target in epithelial ovarian cancerCancer Epidemiol201236549049622818908
   PubMed Web of Science ®Google Scholar
• SealfonSCChuTTRNA and DNA microarraysMethods Mol Biol201167133420967621
   PubMedGoogle Scholar
• RaghavachariNBarbJYangYA systematic comparison and evaluation of high density exon arrays and RNA-seq technology used to unravel the peripheral blood transcriptome of sickle cell diseaseBMC Med Genomics201252822747986
   PubMed Web of Science ®Google Scholar
• RhodesDRYuJShankerKONCOMINE: a cancer micro-array database and integrated data-mining platformNeoplasia2004611615068665
   PubMed Web of Science ®Google Scholar
• RhodesDRKalyana-SundaramSMahavisnoVOncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profilesNeoplasia20079216618017356713
   PubMed Web of Science ®Google Scholar
• TangZLiCKangBGaoGLiCZhangZGEPIA: a web server for cancer and normal gene expression profiling and interactive analysesNucleic Acids Res201745W1W98W10228407145
   PubMed Web of Science ®Google Scholar
• GyorffyBLánczkyASzállásiZImplementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patientsEndocr Relat Cancer201219219720822277193
   PubMed Web of Science ®Google Scholar
• CeramiEGaoJDogrusozUThe cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics dataCancer Discov20122540140422588877
   PubMed Web of Science ®Google Scholar
• MontojoJZuberiKRodriguezHBaderGDMorrisQGeneMANIA: fast gene network construction and function prediction for CytoscapeF1000Res2014315325254104
   PubMedGoogle Scholar
• Huang daWShermanBTLempickiRASystematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNat Protoc200941445719131956
   PubMed Web of Science ®Google Scholar
• Huang daWShermanBTLempickiRABioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene listsNucleic Acids Res200937111319033363
   PubMed Web of Science ®Google Scholar
• HendrixNDWuRKuickRSchwartzDRFearonERChoKRFibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomasCancer Res20066631354136216452189
   PubMed Web of Science ®Google Scholar
• AdibTRHendersonSPerrettCPredicting biomarkers for ovarian cancer using gene-expression microarraysBr J Cancer200490368669214760385
   PubMed Web of Science ®Google Scholar
• LuKHPattersonAPWangLSelection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysisClin Cancer Res200410103291330015161682
   PubMed Web of Science ®Google Scholar
• YoshiharaKTajimaAKomataDGene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosisCancer Sci200910081421142819486012
   PubMed Web of Science ®Google Scholar
• KhelwattySAEssapenSSeddonAMModjtahediHPrognostic significance and targeting of HER family in colorectal cancerFront Biosci (Landmark Ed)20131839442123276932
   PubMed Web of Science ®Google Scholar
• MontemurroFScaltritiMBiomarkers of drugs targeting HER-family signalling in cancerJ Pathol2014232221922924105684
   PubMed Web of Science ®Google Scholar
• MoorcraftSYChauIInvestigational therapies targeting the ErbB family in oesophagogastric cancerExpert Opin Investig Drugs2014231013491363
   PubMed Web of Science ®Google Scholar
• ReyesHDThielKWCarlsonMJComprehensive profiling of EGFR/HER receptors for personalized treatment of gynecologic cancersMol Diagn Ther201418213715124403167
   PubMed Web of Science ®Google Scholar
• MehnerCObergALGoergenKMEGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature reviewGenes Cancer201785–658959928740577
   PubMedGoogle Scholar
• SasakiTHirokiKYamashitaYThe role of epidermal growth factor receptor in cancer metastasis and microenvironmentBiomed Res Int20132013546318823986907
   PubMed Web of Science ®Google Scholar
• LiuXFengCLiuJThe importance of EGFR as a biomarker in molecular apocrine breast cancerHum Pathol20187711029409930
   PubMed Web of Science ®Google Scholar
• CorcoranRBAndréTAtreyaCECombined BRAF, EGFR, and MEK inhibition in patients with BRAFV600E-mutant colorectal cancerCancer Discov20188442844329431699
   PubMed Web of Science ®Google Scholar
• WangYNLeeHHChouCKAngiogenin/ribonuclease 5 Is an EGFR ligand and a serum biomarker for erlotinib sensitivity in pancreatic cancerCancer Cell201833475276929606349
   PubMed Web of Science ®Google Scholar
• SchwanhäusserBBusseDLiNGlobal quantification of mammalian gene expression controlNature2011473734733734221593866
   PubMed Web of Science ®Google Scholar
• SkirnisdóttirISorbeBSeidalTThe growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinomaInt J Gynecol Cancer200111211912911328410
   PubMed Web of Science ®Google Scholar
• WangKLiDSunLHigh levels of EGFR expression in tumor stroma are associated with aggressive clinical features in epithelial ovarian cancerOnco Targets Ther2016937738626855586
   PubMed Web of Science ®Google Scholar
• de GraeffPCrijnsAPTen HoorKAThe ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancerBr J Cancer200899234134918628764
   PubMed Web of Science ®Google Scholar
• de GraeffPCrijnsAPde JongSModest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysisBr J Cancer2009101114915919513073
   PubMed Web of Science ®Google Scholar
• PerezEACortésJGonzalez-AnguloAMBartlettJMHER2 testing: current status and future directionsCancer Treat Rev201440227628424080154
   PubMed Web of Science ®Google Scholar
• WolffACHammondMEHicksDGRecommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateJ Clin Oncol201331313997401324101045
   PubMed Web of Science ®Google Scholar
• BallingerTJSandersMEAbramsonVGCurrent HER2 testing recommendations and clinical relevance as a predictor of response to targeted therapyClin Breast Cancer201515317118025516402
   PubMed Web of Science ®Google Scholar
• RakhaEAPigeraMShaabanANational guidelines and level of evidence: comments on some of the new recommendations in the American Society of Clinical Oncology and the College of American Pathologists human epidermal growth factor receptor 2 guidelines for breast cancerJ Clin Oncol2015331113011302
   PubMed Web of Science ®Google Scholar
• TannerBKreutzEWeikelWPrognostic significance of c-erB-2 mRNA in ovarian carcinomaGynecol Oncol19966222682778751560
   PubMed Web of Science ®Google Scholar
• MedenHKuhnWOverexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factorEur J Obstet Gynecol Reprod Biol19977121731799138962
   PubMed Web of Science ®Google Scholar
• TomićSIlić ForkoJBabićDSundovDKuretSAndelinovićSc-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinomaCroat Med J200344442943412950146
   PubMed Web of Science ®Google Scholar
• LuoHXuXYeMShengBZhuXThe prognostic value of HER2 in ovarian cancer: a meta-analysis of observational studiesPLoS One2018131e019197229381731
   PubMed Web of Science ®Google Scholar
• WangZErbB receptors and cancerMethods Mol Biol2017165233528791631
   PubMedGoogle Scholar
• ZhangNChangYRiosAAnZHER3/ErbB3, an emerging cancer therapeutic targetActa Biochim Biophys Sin (Shanghai)2016481394826496898
   PubMed Web of Science ®Google Scholar
• NielsenTOFriis-HansenLPoulsenSSFederspielBSorensenBSExpression of the EGF family in gastric cancer: down regulation of HER4 and its activating ligand NRG4PLoS One201494e9460624728052
   PubMed Web of Science ®Google Scholar
• HamburgerAWThe role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapiesJ Mammary Gland Biol Neoplasia200813222523318425425
   PubMed Web of Science ®Google Scholar
• TannerBHasencleverDSternKErbB-3 predicts survival in ovarian cancerJ Clin Oncol200624264317432316896008
   PubMed Web of Science ®Google Scholar
• MaJLyuHHuangJLiuBTargeting of erbB3 receptor to overcome resistance in cancer treatmentMol Cancer20141310524886126
   PubMed Web of Science ®Google Scholar
• MujooKChoiBKHuangZZhangNAnZRegulation of ERBB3/HER3 signaling in cancerOncotarget2014521102221023625400118
   PubMedGoogle Scholar
• Muraoka-CookRSFengSMStrunkKEEarpHSErbB4/HER4: role in mammary gland development, differentiation and growth inhibitionJ Mammary Gland Biol Neoplasia200813223524618437540
   PubMed Web of Science ®Google Scholar
• HollménMEleniusKPotential of ErbB4 antibodies for cancer therapyFuture Oncol201061375320021208
   PubMed Web of Science ®Google Scholar
• WaliVBGilmore-HebertMMamillapalliROverexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesisBreast Cancer Res201416650125516216
   PubMed Web of Science ®Google Scholar
• MishraRHankerABGarrettJTGenomic alterations of ERBB receptors in cancer: clinical implicationsOncotarget201786911437111439229371993
   PubMedGoogle Scholar